The Clinical Trial Supplies market is expected to grow from US$2.70 Bn in 2024 to US$4.79 Bn by 2033 with a CAGR of 6.58% during the forecast period from 2025 to 2033. Rising chronic disease incidence, tightening regulations, globalization of clinical trials, advances in biotechnology, introduction of biosimilars and orphan drugs, and newer technologies such as blockchain and IoT in supply chain management are the drivers for this market.
Clinical trial supply basically aims at the provision to participants of the products under study, such as drugs, biologics, or medical devices, whilst the rest involves those necessary for data collection, patient monitoring, and storage of materials during trials. Management of clinical supplies is very important so that the right products are at the right location on time so as to avoid delays or errors with the product in the course of the trial. Moreover, clinical trial supplies play an essential role in conducting clinical trials without compromising their integrity, ensuring safety on the individual participants' part, and fulfilling the regulatory demands of every phase of the research process.
2. Packaging, Labeling and Storage
3. Logistics and Distribution
2. Phase II
3. Phase III
4. Others
2. Cardiovascular Diseases
3. CNS and Mental Disorders
4. Others
2. Biopharmaceuticals Industry
3. Pharmaceuticals Industry
4. Others
2. Key Persons
3. Recent Development & Strategies
4. Product Portfolio
5. Financial Insights
2. Biocair
3. DHL
4. Thermo Fisher Scientific Inc.
5. Marken
6. Paraxel International Corporation
7. Sharp Services, LLC
8. PCI Pharma Services
General Overview of Clinical Trial Supplies
Clinical trial supplies are those materials and products used in the conduct of clinical trials, from investigational drugs and devices to laboratory reagents, packaging, and labeling materials. Of course, they play a very critical role in conducting clinical research in that they ensure the supply of these materials supports the execution of those trials that are effective, safe, and compliant with all appropriate regulatory standards.Clinical trial supply basically aims at the provision to participants of the products under study, such as drugs, biologics, or medical devices, whilst the rest involves those necessary for data collection, patient monitoring, and storage of materials during trials. Management of clinical supplies is very important so that the right products are at the right location on time so as to avoid delays or errors with the product in the course of the trial. Moreover, clinical trial supplies play an essential role in conducting clinical trials without compromising their integrity, ensuring safety on the individual participants' part, and fulfilling the regulatory demands of every phase of the research process.
Driving Factors for Growth in Clinical Trial Supplies Market
Increase in Chronic Diseases and Medicinal Research
The chief driving forces behind the growth of the clinical trial supplies market are chronic diseases, such as cancer, diabetes, and cardiovascular disease. With the rising incidence of these diseases, the chances of new treatments and therapies increase, thereby increasing the clinical trials. For these trials, a wide variety of supplies may be needed, such as investigational drugs, testing kits, and medical devices. So, the demand for these clinical trial supplies also increases. The growing significance of personalized medicine in chronic conditions further boosts the demand for specific trial supplies.Regulatory Advancements and Compliance
Tighter regulations across the world are compelling the clinical trial supplies market to grow. West based Governments as well as the regulatory bodies, like FDA and EMA have been increasingly stringent about the clinical trials that must guarantee safety, efficacy, and transparency. It compels clinical trial supplies to meet strictly controlled quality control, packaging, and labeling standards, and therefore, the demand for compliant and reliable trial materials increases. As regulations are enhancing, the space of clinical trial supplies is increasing to fulfill the higher demands for ensuring the success of the trials.Globalization of Clinical Trials
The other key driver of the clinical trial supplies market is the globalization of clinical trials. Pharmaceutical companies and research organizations engage in clinical trials in various regions, including emerging markets. As a result, there is a requirement for proper management and global distribution of clinical trial supplies, ensuring quality throughout and on-time delivery across all parts of the world. The rising trend of globalization triggers the need for advanced logistics, packaging, and tracking capabilities that spur the market for clinical trial supplies. The ability to source and supply materials globally accelerates research and pushes new therapies onto the market more quickly.USA Clinical Trial Supplies Market
The USA is one of the biggest markets for clinical trial supplies in the world, due to the high level of healthcare infrastructure in the region, increasing clinical trials, and growing importance toward research and development. Growing chronic diseases and the necessity of more customized medicine are driving the demand for specialized clinical trial supplies, including investigational drugs, devices, and packaging materials. The market also receives support from a strict standard of regulation, quality and safety of the trial supplies. Further, technological advancements in the supply chain management, such as temperature-controlled shipping and digital monitoring, are also augmenting the US market growth. According to the U.S. National Library of Medicine, as of June 2023, about 55,483 interventional clinical studies were posted with results on Clinicatrial.gov. Website.Clinical Trial Supplies Market in France
The market for clinical trial supplies in France is in a steady growth pattern due to its strong healthcare infrastructure and strong participation in clinical research. France, to this date, is regarded as the world's hub for pharmaceutical and biotechnology companies which are actively conducting operations and thus requiring the majority of the supplies needed for clinical trials, from investigational drugs to medical devices and even the materials needed for packaging. With increased chronic conditions and attention given to personalized medicine, custom supply orders for trials are on the rise. The strict regulations of the French Medicines Agency (ANSM) and the European Medicines Agency (EMA) thus help harden standards towards the safety and efficacy of clinical trials that get conducted in the market. In fact, with its beginning in 2019, the French government unveiled the Health Innovation 2030 plan with a clear intent to make France the leader in clinical trials in Europe. This includes design of national database of clinical trials to speed up expedience and the capacity in recruitment.India Clinical Trial Supplies Market
Clinical trial supplies in Indian market are growing rapidly. More pharmaceutical activity in India coupled with participation in international clinical research further added fuel to the growth in the sector. Most of the clinical trial activity in India made affordable and highly skilled; therefore, it remains an interested location for multinational pharmaceutical companies. Constantly rising prevalence of chronic diseases and demand for innovative therapies add fuel to the requirement for clinical trial supplies, including investigational drugs, medical devices, and laboratory reagents. India's evolving regulatory framework and adherence to global standards, such as those set by the Central Drugs Standard Control Organization, enhance market growth and reliability. In March 2024, Eli Lilly and Company (India) Pvt. Ltd. started Phase III clinical trials for orforglipron, an oral anti-obesity agent. This is a drug that's targeted at patients suffering from Type 2 diabetes or obesity/overweight, thus reducing cardiovascular disease risks.Company Clinical Trial Supplies Analysis
Almac Group Ltd., Biocair, DHL, Thermo Fisher Scientific Inc., Marken, Paraxel International Corporation, Sharp Services, LLC, and PCI Pharma Services are the major competitors of the Clinical Trial Supplies market.Service- Industry is divided into 3 viewpoints:
1. Product Manufacturing2. Packaging, Labeling and Storage
3. Logistics and Distribution
Phase- Industry is divided into 4 viewpoints:
1. Phase I2. Phase II
3. Phase III
4. Others
Therapeutic Area - Industry is divided into 4 viewpoints:
1. Oncology2. Cardiovascular Diseases
3. CNS and Mental Disorders
4. Others
End Use- Industry is divided into 4 viewpoints:
1. Medical Device Industry2. Biopharmaceuticals Industry
3. Pharmaceuticals Industry
4. Others
Countries- Industry is divided into 25 viewpoints:
North America
- United States
- Canada
Europe
- France
- Germany
- Italy
- Spain
- United Kingdom
- Belgium
- Netherlands
- Turkey
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Thailand
- Malaysia
- Indonesia
- New Zealand
Latin America
- Brazil
- Mexico
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- United Arab Emirates
All companies have been covered with 5 Viewpoints
1. Overview2. Key Persons
3. Recent Development & Strategies
4. Product Portfolio
5. Financial Insights
Company Analysis
1. Almac Group Ltd.2. Biocair
3. DHL
4. Thermo Fisher Scientific Inc.
5. Marken
6. Paraxel International Corporation
7. Sharp Services, LLC
8. PCI Pharma Services
Table of Contents
1. Introduction2. Research & Methodology3. Executive Summary5. Global Clinical Trial Supplies Market
4. Market Dynamics
6. Market Share Analysis
7. Services
8. Phase
9. Therapeutic Area
10. End Use
11. Country
12. Porter’s Five Analysis
13. SWOT Analysis
14. Company Analysis
Companies Mentioned
- Almac Group Ltd.
- Biocair
- DHL
- Thermo Fisher Scientific Inc.
- Marken
- Paraxel International Corporation
- Sharp Services, LLC
- PCI Pharma Services
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 115 |
| Published | November 2024 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 2.7 Billion |
| Forecasted Market Value ( USD | $ 4.79 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 8 |
